ReviewScience China. Life sciences2024
Chinese Society of Cardiology guidelines on the diagnosis and treatment of adult fulminant myocarditis.
Abstract readReview
In one paragraph
Review in Science China. Life sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
10.1field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 25 citations in OpenAlex.
- The efficacy and safety of hydroxychloroquine in patients with chronic inflammatory cardiomyopathy: a multicenter randomized study (HYPIC trial).BMC medicine · 2025Trial
- Accurate pathologic classification of aggressive myocarditis improves insights into patient precise medicine.Fundamental research · 2026Article
- Heart-Rate-Dependent Right-to-Left Shunting Through a Patent Foramen Ovale in Severe Right Ventricular Dysfunction: A Case Report.Journal of clinical medicine · 2026Article
- A novel evaluation indicator for pediatric fulminant myocarditis: diagnostic and prognostic value of the HALP score.BMC pediatrics · 2026Article
- Danhong Injection targets CaMKII through Dihydrotanshinone I to alleviate cardiomyocyte death and inflammation in viral myocarditis.Science China. Life sciences · 2026Article
- The clinicopathologic features of fulminant myocarditis.Journal of advanced research · 2026Article
- Diplopia as the herald of fulminant myocarditis in undifferentiated connective tissue disease: a case report.Frontiers in cardiovascular medicine · 2026Article
- Case report: Efgartigimod combined with intravenous methylprednisolone in a case of co-occurrence of unexplained myasthenia gravis, inflammatory myopathy, and fulminant myocarditis.Frontiers in immunology · 2026Article
- Evaluation of Prognosis and Risk Factors of Fulminant Myocarditis Complicated with Malignant Arrhythmia.Journal of cardiovascular development and disease · 2025Article
- Successful VA-ECMO rescue of life-threatening cardiotoxicity following paclitaxel and cisplatin neoadjuvant chemotherapy for laryngeal cancer: a case report.BMC cardiovascular disorders · 2025Article
- Novel insights into short-term troponin remeasurement and long-term cardiac function and structure following fulminant myocarditis.International journal of cardiology. Heart & vasculature · 2025Article
- Fulminant Myocarditis Secondary to Cardiac T-Cell Lymphoma.JACC. Case reports · 2025Article
- Long-term left ventricular ejection function in fulminant and non-fulminant myocarditis: A multicenter study in China.International journal of cardiology. Heart & vasculature · 2025Article
- Deep insight into cytokine storm: from pathogenesis to treatment.Signal transduction and targeted therapy · 2025Review
- Predictive Value of Neutrophil-to-Lymphocyte Ratio for Immune Checkpoint Inhibitor-Related Myocarditis Among Patients Treated for Non-Small-Cell Lung Cancer.Cancer innovation · 2025Article
- High-throughput untargeted metabolomic profiling of urinary biomarkers in acute myocarditis patients: a cross-sectional study.Scientific reports · 2025Article
- Development of a clinical prediction model for acute myocarditis using coronary computed tomography angiography-based radiomics.Cardiovascular diagnosis and therapy · 2025Article
- Angiotensin-Converting Enzyme Inhibitors Mitigate Development of Chronic Persistent Cardiac Dysfunction Following Fulminant Myocarditis: A Multicenter Retrospective Study in China.International journal of general medicine · 2025Article
- Association of inflammatory index with the severity of disease in patients with acute myocarditis: A retrospective observational study.Frontiers in endocrinology · 2025Observational
- Lactate Dehydrogenase Indicates Development From Fulminant Myocarditis to Chronic Persistent Myocarditis: A Multicenter Retrospective Cohort Study in China.International journal of general medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
43 authors at 20 institutions in 1 country.
Chinese Society of Cardiology, Chinese Medical Association, Writing Group
Jiangang Jiang *Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Hongyang Shu *Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Dao Wen WangTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. dwwang@tjh.tjmu.edu.cn.
Rutai HuiFuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China.
Chenze LiZhongnan Hospital of Wuhan University, Wuhan, 430062, China.
Xiao RanTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Hong WangTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Jing ZhangFuwai Huazhong Cardiovascular Hospital, Zhengzhou, 450003, China.
Shaoping NieBeijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China.
Guanglin CuiTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Dingcheng XiangGuangzhou General Hospital of Guangzhou Military Command, Guangzhou, 510010, China.
Qun ShaoHarbin Medical University Cancer Hospital, Harbin, 150081, China.
Shengyong XuUnion Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Ning ZhouTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Yuming LiTaida Hospital, Tianjin, 300457, China.
Wei GaoPeking University Third Hospital, Beijing, 100191, China.
Yuguo ChenQilu Hospital of Shandong University, Jinan, 250012, China.
Yuan BianQilu Hospital of Shandong University, Jinan, 250012, China.
Guoping WangTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Liming XiaTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Yan WangTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Chunxia ZhaoTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Zhiren ZhangHarbin Medical University Cancer Hospital, Harbin, 150081, China.
Yuhua ZhaoKanghua Hospital, Dongguan, Guangzhou, 523080, China.
Jianan WangSecond Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, 310003, China.
Shaoliang ChenNanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
Hong JiangRenmin Hospital of Wuhan University, Wuhan, 430060, Wuhan, China.
Jing ChenRenmin Hospital of Wuhan University, Wuhan, 430060, Wuhan, China.
Xianjin DuRenmin Hospital of Wuhan University, Wuhan, 430060, Wuhan, China.
Mao ChenWest China Hospital, Sichuan University, Chengdu, 610044, China.
Yinxian SunFirst Hospital of China Medical University, Shenyang, 110002, China.
Sheng LiTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Hu DingTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Xueping MaGeneral Hospital of Ningxia Medical University, Yinchuan, 750003, China.
Hesong ZengTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Li LinTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Shenghua ZhouThe Second Xiangya Hospital, Central South University, Changsha, 410012, China.
Likun MaThe First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230002, China.
Ling TaoThe First Affiliated Hospital of Air Force Medical University, Xi'an, 710032, China.
Juan ChenCentral Hospital of Wuhan City, Wuhan, 430014, China.
Yiwu ZhouTongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Xiaomei GuoTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Huazhong University of Science and Technology · CNTongji Hospital · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNQilu Hospital of Shandong University · CNThird Affiliated Hospital of Harbin Medical University · CNWuhan University · CNAir Force Medical University · CNCapital Medical University · CNCentral Hospital of Wuhan · CNCentral South University · CNChina Medical University · CNGeneral Hospital of Guangzhou Military Command · CNGuhua Hospital · CNNanjing Medical University · CNNingxia Medical University General Hospital · CNPeking University Third Hospital · CNRenmin Hospital of Wuhan University · CNSecond Affiliated Hospital of Zhejiang University · CNTianjin Hospital · CNUniversity of Science and Technology of China · CN
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fulminant myocarditis is an acute diffuse inflammatory disease of myocardium. It is characterized by acute onset, rapid progress and high risk of death. Its pathogenesis involves excessive immune activation of the innate immune system and formation of inflammatory storm. According to China's practical experience, the adoption of the "life support-based comprehensive treatment regimen" (with mechanical circulation support and immunomodulation therapy as the core) can significantly improve the survival rate and long-term prognosis. Special emphasis is placed on very early identification,very early diagnosis,very early prediction and very early treatment.
Indexed as
MyocarditisAdultCardiologyChinaHumansPrognosisSocieties, Medicalcytokine stormdiagnosisfulminant myocarditisguidelineslife support-based comprehensive treatment regimenoveractivation of immunitytreatment
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.